Hibi T, Rela M, Eason J, Line PD, Fung J, Sakamoto S, Selzner N, Man NK, Ghobrial RM, Sapisochin G.
Liver Transplantation for Colorectal and Neuroendocrine Liver Metastases and Hepatoblastoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference.
Transplantation. 2020 Mar 23.

Hibi T, Chen Y, Kim JI, Lee MD, Matsuura T, Ueno T.
Current status of intestinal transplantation in East Asia
Curr Opin Organ Transplant. 2020 Apr;25(2):165-168.

Kuramitsu K, Fukumoto T, Egawa H, Ohdan H, Umeshita K, Uemoto S, Hibi T, Kasahara M, Yoshizumi T, Mizuta K, Shimamura T, Furukawa H.
A Multicenter Japanese Survey Assessing the Long-Term Outcomes of Liver Re-transplantation using Living Donor Grafts
Transplantation. 2020 Apr;104(4):754-761.

Sapisochin G, Hibi T, Ghobrial M, Man K.
The ILTS Consensus Conference on Transplant Oncology: Setting the Stage.
Transplantation. 2020 Mar 23.

Mehta N, Bhangui P, Yao FY, Mazzaferro V, Toso C, Akamatsu N, Durand F, Ijzermans J, Polak W, Zheng S, Roberts JP, Sapisochin G, Hibi T, Kwan NM, Ghobrial M, Soin A.
Liver Transplantation for Hepatocellular Carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference.
Transplantation. 2020 Mar 23.

Sapisochin G, Javle M, Lerut J, Ohtsuka M, Ghobrial M, Hibi T, Kwan NM, Heimbach J.
Liver Transplantation for Cholangiocarcinoma and Mixed Hepatocellular-cholangiocarcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference.
Transplantation. 2020 Mar 23.

Berenguer M, Burra P, Ghobrial M, Hibi T, Metselar H, Sapisochin G, Bhoori S, Man NK, Mas V, Ohira M, Sangro B, van der Laan LJW.
Posttransplant management of recipients undergoing liver transplantation for hepatocellular carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference.
Transplantation. 2020 Mar 23.

Minagawa T, Yamazaki K, Masugi Y, Tsujikawa H, Ojima H, Hibi T, Abe Y, Yagi H, Kitago M, Shinoda M, Itano O, Kitagawa Y, Sakamoto M.
Activation of extracellular signal-regulated kinase is associated with hepatocellular carcinoma with aggressive phenotypes.
Hepatol Res. 2020 Mar;50(3):353-364.

Koizumi S, Yamashita S, Matsumura S, Takeda K, Minagawa T, Kobayashi S, Hibi T, Shinoda M, Endo I, Tanabe M, Yamamoto M, Otsubo T.
Significance of a preoperative tumor marker gradient for predicting microvascular invasion in cases of hepatocellular carcinoma.
Mol Clin Oncol. 2020 Mar;12(3):290-294.

Yamamoto H, Sambommatsu Y, Ibuki S, Shimata K, Sugawara Y, Hibi T.
Long-term outcomes of living donor liver transplantation in patients with a prior history of nonhepatic malignancy.
Biosci Trends. 2020 Mar 16;14(1):42-47.

Yoshii D, Inomata Y, Yamamoto H, Irie T, Kadohisa M, Okumura K, Isono K, Honda M, Hayashida S, Oya Y, Hibi T.
The duodenal tube test is more specific than hepatobiliary scintigraphy for identifying bile excretion in the differential diagnosis of biliary atresia.
Surgery Today. 2020 Apr 20.

Ishii M, Itano O, Shinoda M, Kitago M, Abe Y, Hibi T, Yagi H, Takeuchi A, Tsujikawa H, Abe T, Kitagawa Y.
Pre-hepatectomy type IV collagen 7S predicts post-hepatectomy liver failure and recovery.
World J Gastroenterol. 2020 Feb 21;26(7):725-739.

Kadohisa M, Inomata Y, Uto K, Hayashida S, Ohya Y, Yamamoto H, Sugawara Y, Hibi T.
Impact of Donor Age on the Outcome of Living-donor Liver Transplantation: Special Consideration to the Feasibility of Using Elderly Donors.
Transplantation. 2020 Mar 30.